fda warning letter hims compounded semaglutide september 2025 Why the Issued 30 Letters to Telehealth Sites Marketing GLP-1s U.S. FDA sends drug advertising

Borenstein M, Hedges LV, Higgins JP, Rothstein HR

Providers often recommend delaying GLP-1 therapy until after breastfeeding ends, though case-by-case risk-benefit discussions may occur in specific clinical contexts

Standard vial sizes include 5mg, 10mg, and 20mg

doi:10.2337/diabetes.47.11.1663 These references provide a comprehensive overview of the clinical evidence regarding the association between semaglutide use and acid reflux, offering valuable insights into its prevalence, mechanisms, and management strategies for healthcare providers and patients

Naltrexone (Revia) is an opioid receptor antagonist that competitively binds to opioid receptors